» Articles » PMID: 30755789

The Dynamic Side of the Warburg Effect: Glycolytic Intermediate Storage As Buffer for Fluctuating Glucose and O  supply in Tumor Cells

Overview
Journal F1000Res
Date 2019 Feb 16
PMID 30755789
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

: Tumor cells often show altered metabolism which supports uncontrolled proliferation. A classic example is the Warburg effect: high glucose uptake and lactate production despite sufficient oxygen supply. Remarkably, tumor cells can transiently take up glucose even an order of magnitude faster when glucose is reintroduced after depletion. Regulation and significance of this high glucose uptake are investigated here. : A new computational model was developed which reproduces two types of experimental data on Ehrlich ascites tumor cells: measurements by Otto Warburg of the average aerobic glycolytic rate during one hour (Warburg effect), and fast metabolic responses measured by others during the first minutes after reintroducing glucose. The model is subsequently extended with equations for glucose and O  transport to predict the role of metabolism during fluctuations of blood flow in tumor tissue. : Model analysis reveals dynamic regulation of the head section of glycolysis where glucose uptake and phosphorylation occur. The head section is disinhibited slowly when concentrations of glycolytic intermediates fall, causing glucose uptake rate to considerably exceed that found by Warburg. The head section is partially inhibited in about a minute when sufficient glucose has been taken up. Simulations predict that tumors greedily take up glucose when blood flow resumes after periods of low flow. The cells then store glucose as fructose 1,6-bisphosphate and other glycolytic intermediates. During subsequent periods of low flow that cause O and glucose depletion these stores are used for ATP production and biomass. : The powerful glycolytic system in tumors not only synthesizes ATP at high steady rates, but can also store glycolytic intermediates to buffer temporary oxygen and nutrient shortages for up to 10 minutes. The head section of glycolysis in tumor cells, disinhibited during glucose shortages, becomes very efficient at stealing glucose from other cells, even at low glucose concentrations.

Citing Articles

3D Modeling: Insights into the Metabolic Reprogramming of Cholangiocarcinoma Cells.

Ciufolini G, Zampieri S, Cesaroni S, Pasquale V, Bonanomi M, Gaglio D Cells. 2024; 13(18.

PMID: 39329720 PMC: 11430555. DOI: 10.3390/cells13181536.


Pyruvate Kinase Differentially Alters Metabolic Signatures during Head and Neck Carcinogenesis.

Huang P, Chang C, Lin Y, Chen C, Chen T, Chuang L Int J Mol Sci. 2023; 24(23).

PMID: 38068962 PMC: 10706023. DOI: 10.3390/ijms242316639.


Acidic and Hypoxic Microenvironment in Melanoma: Impact of Tumour Exosomes on Disease Progression.

Boussadia Z, Gambardella A, Mattei F, Parolini I Cells. 2021; 10(12).

PMID: 34943819 PMC: 8699343. DOI: 10.3390/cells10123311.


Lactate Metabolism and Signaling in Tuberculosis and Cancer: A Comparative Review.

Kiran D, Basaraba R Front Cell Infect Microbiol. 2021; 11:624607.

PMID: 33718271 PMC: 7952876. DOI: 10.3389/fcimb.2021.624607.


The dynamic side of the Warburg effect: glycolytic intermediate storage as buffer for fluctuating glucose and O  supply in tumor cells.

van Beek J F1000Res. 2019; 7:1177.

PMID: 30755789 PMC: 6352925. DOI: 10.12688/f1000research.15635.2.

References
1.
Ainscow E, Brand M . Top-down control analysis of ATP turnover, glycolysis and oxidative phosphorylation in rat hepatocytes. Eur J Biochem. 1999; 263(3):671-85. DOI: 10.1046/j.1432-1327.1999.00534.x. View

2.
Kemp A, MENDEL B . How does the Ehrlich ascites tumour obtain its energy for growth?. Nature. 1957; 180(4577):131-2. DOI: 10.1038/180131a0. View

3.
COE E . Transient isolation of the hexokinase reaction from the glycolytic sequence on initiation of glycolysis in ascites tumor cells. Biochem Biophys Res Commun. 1970; 38(6):1105-12. DOI: 10.1016/0006-291x(70)90353-0. View

4.
Calmettes G, Ribalet B, John S, Korge P, Ping P, Weiss J . Hexokinases and cardioprotection. J Mol Cell Cardiol. 2014; 78:107-15. PMC: 4268312. DOI: 10.1016/j.yjmcc.2014.09.020. View

5.
van Heerden J, Wortel M, Bruggeman F, Heijnen J, Bollen Y, Planque R . Lost in transition: start-up of glycolysis yields subpopulations of nongrowing cells. Science. 2014; 343(6174):1245114. DOI: 10.1126/science.1245114. View